Literature DB >> 10885417

The current single exhalation method of measuring exhales nitric oxide is affected by airway calibre.

L P Ho1, F T Wood, A Robson, J A Innes, A P Greening.   

Abstract

The authors have observed that some patients with acute exacerbations of asthma do not have substantially higher levels of exhaled nitric oxide (NO). The study examined whether this could be explained by the effect of airway calibre on exhaled NO. Exhaled NO, height and forced expiratory volume in one second (FEV1) were measured in 12 steroid-naive asthmatics and 17 normal subjects. For comparison, another group of patients with airways disease (34 cystic fibrosis patients) were also studied. In 20 asthmatics (on various doses of inhaled steroids, 0-3,200 microg x day-1), exhaled NO was measured before and after histamine challenge (immediately after reaching the provocative concentration causing a 20% fall in FEV1) and in 12 of these patients, also after nebulized salbutamol to restore FEV1 to baseline. Studies were also conducted to examine possible confounding effects of repeated spirometry (as would occur in histamine challenge) and nebulized salbutamol alone in exhaled NO levels. Exhaled NO was measured using a single exhalation method with a chemiluminescence analyser at a constant flow rate and mouth pressure. There was a significant correlation between FEV1 and exhaled NO in steroid naive asthmatics (r=0.9, p<0.001) and cystic fibrosis patients (r=-0.48, p<0.05) but not in normal subjects (r=-0.13, p=0.61). Exhaled NO decreased significantly after histamine challenge and returned to baseline after bronchodilation by nebulized salbutamol (mean+/-SEM: 23.6+/-3.6 parts per billion (ppb) (prehistamine), 18.2+/-2.7 ppb (posthistamine) and 23.6+/-3.8 ppb (postsalbutamol) p=0.001). Repeated spirometry and nebulized salbutamol did not affect exhaled NO measurements significantly. Exhaled nitric oxide levels appear to be lower in circumstances of smaller airway diameter. Hence, within a subject nitric oxide levels may be artefactually decreased during bronchoconstriction. This may be caused by increased airflow velocity in constricted airways when the exhalation rate is kept constant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885417     DOI: 10.1034/j.1399-3003.2000.01506.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Exhaled nitric oxide levels during treatment of pediatric acute asthma exacerbations and association with the need for hospitalization.

Authors:  Kyle A Nelson; Pearlene Lee; Kathryn Trinkaus; Robert C Strunk
Journal:  Pediatr Emerg Care       Date:  2011-04       Impact factor: 1.454

2.  Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.

Authors:  Alain Michils; Amaryllis Haccuria; Sebastien Michiels; Alain Van Muylem
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

3.  Obesity, sedentary lifestyle, and exhaled nitric oxide in an early adolescent cohort.

Authors:  Bess M Flashner; Sheryl L Rifas-Shiman; Emily Oken; Carlos A Camargo; Thomas J Platts-Mills; Lisa Workman; Augusto A Litonjua; Diane R Gold; Mary B Rice
Journal:  Pediatr Pulmonol       Date:  2019-12-05

4.  Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma.

Authors:  F L M Ricciardolo; M C Timmers; J K Sont; G Folkerts; P J Sterk
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 5.  Partitioned exhaled nitric oxide to non-invasively assess asthma.

Authors:  James L Puckett; Steven C George
Journal:  Respir Physiol Neurobiol       Date:  2008-07-31       Impact factor: 1.931

6.  Electronic nose breathprints are independent of acute changes in airway caliber in asthma.

Authors:  Zsofia Lazar; Niki Fens; Jan van der Maten; Marc P van der Schee; Ariane H Wagener; Selma B de Nijs; Erica Dijkers; Peter J Sterk
Journal:  Sensors (Basel)       Date:  2010-10-12       Impact factor: 3.576

7.  Modeling of the Nitric Oxide Transport in the Human Lungs.

Authors:  Cyril Karamaoun; Alain Van Muylem; Benoît Haut
Journal:  Front Physiol       Date:  2016-06-28       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.